Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms

Area of Science:

• Vascular Biology
• Inflammation Research
• Biochemistry

Background:

• Human abdominal aortic aneurysm (AAA) is a serious condition characterized by the weakening and dilation of the aorta.
• The role of specific inflammatory mediators, such as prostaglandin E2 (PGE2), in AAA pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the expression levels of prostaglandin E2 (PGE2) in human abdominal aortic aneurysm (AAA) tissue.
• To determine the expression patterns of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoforms in AAA tissue.

Main Methods:

• Histologic analysis and whole organ culture of normal and aneurysmal aortic specimens.
• Enzyme-linked immunosorbent assay (ELISA) for PGE2 quantification.
• Immunohistochemical analysis for PGE2 localization and in situ hybridization for COX-1 and COX-2 expression.

Main Results:

• PGE2 production was significantly higher in AAA specimens (67,287 pg/ml) compared to normal aortas (1698 pg/ml) (p < 0.001).
• PGE2 was localized to inflammatory infiltrates in AAAs, primarily associated with macrophage-like cells.
• COX-2 expression was detected in macrophage-like cells within AAA inflammatory infiltrates, while COX-1 expression was minimal in both normal and AAA tissues.

Conclusions:

• Prostaglandin E2 (PGE2) expression is closely associated with the pathogenesis of human abdominal aortic aneurysms (AAAs).
• The cyclooxygenase-2 (COX-2) isoform, expressed by macrophages in the inflammatory infiltrate, is the primary driver of PGE2 production in AAAs.
• COX-2 represents a potential therapeutic target for the pharmacotherapy of AAAs.